 |
|
Prognostic factors and efficacy of human intravenous immunoglobulin G in dogs with idiopathic immune-mediated hemolytic anemia: a retrospective study
So-Young Park, Hakhyun Kim, Byeong-Taek Kang, Ji-Houn Kang, Mhan-Pyo Yang
Korean J Vet Res. 2016;56(3):139-145. Published online 2016 Oct 11 DOI: https://doi.org/10.14405/kjvr.2016.56.3.139
|
|
Citations to this article as recorded by
 The use of high‐dose immunoglobulin M‐enriched human immunoglobulin in dogs with immune‐mediated hemolytic anemia
Jason P. Bestwick, Mellora Sharman, Nat T. Whitley, Caroline Kisielewicz, Barbara J. Skelly, Simon Tappin, Lindsay Kellett‐Gregory, Mayank Seth
Journal of Veterinary Internal Medicine.2022; 36(1): 78. CrossRef Therapeutic Strategies for Treatment of Immune-Mediated Hemolytic Anemia
Robert Goggs
Veterinary Clinics of North America: Small Animal Practice.2020; 50(6): 1327. CrossRef ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs
James W. Swann, Oliver A. Garden, Claire L. Fellman, Barbara Glanemann, Robert Goggs, Dana N. LeVine, Andrew J. Mackin, Nathaniel T. Whitley
Journal of Veterinary Internal Medicine.2019; 33(3): 1141. CrossRef
|